Headache and migraine

British Journal of Hospital Medicine

Volumn 68, Issue 4, 2007, Pages 195-200

  Bahra, Anish ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; AMITRIPTYLINE; ANALGESIC AGENT; CODEINE; CORTICOSTEROID DERIVATIVE; ELETRIPTAN; ERGOT ALKALOID; ERGOTAMINE; ESTROGEN; GABAPENTIN; LITHIUM; METHYSERGIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; RIZATRIPTAN; SUMATRIPTAN; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

CLINICAL FEATURE; CLUSTER HEADACHE; COFFEE; COLA; COMORBIDITY; DEMENTIA; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; GENETIC PREDISPOSITION; HEALTH CARE; HUMAN; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; MIGRAINE AURA; NEUROLOGIC DISEASE; PAIN; PATIENT CARE; PROPHYLAXIS; PSYCHOSIS; QUADRIPLEGIA; RECURRENT DISEASE; REVIEW; RISK FACTOR; TEA; TENSION HEADACHE; TRANSFORMED MIGRAINE;

ACUTE DISEASE; CHRONIC DISEASE; HEADACHE DISORDERS; HUMANS;

EID: 34247372713     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Alter M, Daube JR, Franklin G et al (1994) Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 44(7): 1353-4
2. Bahra A, Goadsby PJ (1998) The comorbidity of migraine and depression: a review. Neurology and Psychiatry 2: 23-7
3. Boyle CAJ (1999) Management of menstrual migraine. Neurology 53(4): S14-S18
4. Chronicle E, Mulleners W (2004) Anticonvulsant drugsfor migraine prophylaxis. Cochrane Database Systematic Reviews 3: CD003226
5. Diener H-C, Dahlöf CG (2000) Headache associated with chronic use of substances. In: Oleson J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. Lippincott Williams and Wilkins: Philadelphia: 871-7
6. Ferrari MD, Goadbsy PJ, Roon KI et al (2002) Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalagia 22: 633-58
7. Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders (II). Cephalagia 24(Suppl 1): 1-160
8. Kudrow L (1982) Paradoxical effects of frequent analgesic use. Adv Neurol 33: 335-41
9. Limmroth V, Katsarava Z, Fritsche G et al (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59(7): 1011-14
10. Lipton RB, Stewart WF, Stone AM (2000) Stratified care vs step care strategies for migraine: results of the Disability in Strategies of Care (DISC) Study. JAMA 284: 754-63
11. Lipton RB, Cady RK, Stewart WF et al (2002) Diagnostic lessons from the Spectrum Study. Neurology 58(Suppl 6): S27-S31
12. Matharu MS, Boes C, Goadbsy PJ et al (2003) Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs 63(16): 1637-77
13. Menken M, Munsat TL, Toole JF (2000) The Global Burden of Disease Study. Implications for Neurology. Arch Neurol 57: 418-20
14. Report of the Quality Standards Committee of the American Academy of Neurology (1995) Practice parameter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology 45: 585-7
15. Russell MB (2001) Genetics of migraine without aura, migraine with aura, migrainous disorder, head trauma migraine without aura and tension-type headache. Cephalalgia 21(7): 778-80
16. Silberstein SD (2000) Practice parameter - Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology for the United States Headache Consortium. Neurology 55: 754-62
17. Silberstein SD, Merriam GR (1997) Sex hormones and headache. In: Goadsby PJ, Silberstien SD, eds. Headache. Butterworth-Heinemann, Woburn, MA: 143-73
18. Silberstein SD, Goadsby PJ (2000) Migraine: Preventative treatment. Cephalagia 22: 491-512
19. Silberstein SD, Lipton RB (2000) Chronic daily headache. Curr Opin Neurol 13(3): 277-83
20. Silver N (2005) Headache (chronic tension-type). Clinical Evidence 14: 1-3
21. Tfelt-Hansen P, McEwan J (2000) Non-steroidal anti-inflammatory drugs in the treatment of the acute migraine attack. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. Lippincott Williams & Wilkins, Philadelphia: 391-7
22. Zeeberg P, Olesen J, Jensen R (2006) Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 26: 1192-8